De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

CaixaBank Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

CaixaBank heeft totale activa van €630.4B en een totaal eigen vermogen van €35.5B. De totale deposito's bedragen €445.1B en de totale leningen bedragen €365.9B leveren een netto rentemarge op van 1.9%. Er is onvoldoende voorziening voor slechte leningen, die momenteel 2.6% van de totale leningen bedragen. Contant geld en kortetermijninvesteringen zijn €12.0B.

Belangrijke informatie

17.8x

Verhouding activa / eigen vermogen

1.9%

Nettorentemarge

Totaal deposito's	€445.13b
Verhouding leningen/deposito's	Passend
Slechte leningen	2.6%
Voorziening voor dubieuze leningen	Laag
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	€12.00b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

CaixaBank (BME:CABK) Is Increasing Its Dividend To €0.1868

Apr 06

Should Shareholders Reconsider CaixaBank, S.A.'s (BME:CABK) CEO Compensation Package?

May 06

News Flash: Analysts Just Made A Captivating Upgrade To Their CaixaBank, S.A. (BME:CABK) Forecasts

Apr 01

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: De Vermogen/vermogensverhouding ( 17.8 x) CABK is gematigd.

Voorziening voor slechte leningen: CABK heeft een lage voorziening voor slechte leningen ( 72 %).

Laag risico verplichtingen: 75% van de verplichtingen van CABK bestaan voornamelijk uit laag risico financieringsbronnen.

Leenniveau: CABK heeft een passend niveau van Leningen/activa-ratio ( 58% ).

Laag risico deposito's: De Leningen-depositoverhouding ( 82% ) van CABK } is passend.

Niveau van slechte leningen: CABK heeft een hoog niveau van slechte leningen ( 2.6 %).

CaixaBank Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

New minor risk - Share price stability

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

First quarter 2024 earnings: Revenues in line with analyst expectations

Criteria in Talks with Potential Investor in Energy Group Naturgy

Dividend of €0.32 announced

Fosun International Reportedly Open to Sale of Stake in Millennium

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

CaixaBank, S.A., Annual General Meeting, Mar 22, 2024

CaixaBank, S.A., Annual General Meeting, Mar 21, 2024

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

CaixaBank, S.A. to Report Q4, 2023 Results on Feb 02, 2024

CaixaBank, S.A. to Report Q4, 2023 Results on Feb 02, 2024

New major risk - Revenue and earnings growth

Sandton Capital Partners LP agreed to acquire a 50.99% stake in Sistemas Técnicos de Encofrados, S.A. from Banco Santander, S.A. (BME:SAN), CaixaBank, S.A. (BME:CABK) and Banco de Sabadell, S.A. (BME:SAB).

Sandton Capital Partners LP agreed to acquire a 50.99% stake in Sistemas Técnicos de Encofrados, S.A. from Banco Santander, S.A. (BME:SAN), CaixaBank, S.A. (BME:CABK) and Banco de Sabadell, S.A. (BME:SAB).

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

CaixaBank (BME:CABK) Is Increasing Its Dividend To €0.1868

Now 21% undervalued

CaixaBank, S.A., Annual General Meeting, Mar 31, 2023

Full year 2022 earnings: Revenues exceed analyst expectations

Now 20% undervalued

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorated over the past week

Now 21% undervalued

Now 22% undervalued

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of €0.12 per share

Investor sentiment improved over the past week

Now 22% undervalued

CaixaBank, S.A., Annual General Meeting, Apr 08, 2022

Investor sentiment improved over the past week

Full year 2021 earnings: EPS exceeds analyst expectations

Third quarter 2021 earnings released: EPS €0.087 (vs €0.087 in 3Q 2020)

Caixabank Announces Plan to Cut More Jobs

Consensus forecasts updated

Upcoming dividend of €0.022 per share

Should Shareholders Reconsider CaixaBank, S.A.'s (BME:CABK) CEO Compensation Package?

Consensus forecasts updated

Consensus revenue estimates increase to €10.6b

Price target increased to €2.77

News Flash: Analysts Just Made A Captivating Upgrade To Their CaixaBank, S.A. (BME:CABK) Forecasts

Analysts increase EPS estimates to €0.28

New 90-day high: €2.41

How Many CaixaBank, S.A. (BME:CABK) Shares Did Insiders Buy, In The Last Year?

Full year 2020 earnings released: EPS €0.23 (vs €0.26 in FY 2019)

Revenue and earnings beat expectations

Analysts update estimates

How Many CaixaBank, S.A. (BME:CABK) Shares Do Institutions Own?

New 90-day high: €2.34

CaixaBank, S.A. (BME:CABK) Is An Attractive Dividend Stock - Here's Why

New 90-day high: €2.29

Caixabank and Bankia Announce Board Appointments

A Look At CaixaBank's (BME:CABK) Share Price Returns

New 90-day high: €2.17

Market bids up stock over the past week

Analysts update estimates

Third quarter earnings released

Third-quarter earnings released: Earnings beat expectations

New 90-day low: €1.62

New 90-day low: €1.74

CaixaBank, S.A. (BME:CABK) entered into a plan of merger to acquire Bankia, S.A. (BME:BKIA) from BFA Tenedora de Acciones S.A.U. and others for €4.3 billion.

Spanish Banks Bankia and Caixabank in Merger Talks

New 90-day low - €1.78

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Ontdek gezonde bedrijven